Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2023-06-30 00:00:00 ET · period of report 2023-05-19 · accession 0001437749-23-019035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-05-19 | ZVRA | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $5.42 | +1,000 | 3,000 | +50% | +$5,420 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-19 | P | A | 1,000 | $5.42 | 3,000 | D | — | — |